Brackmann Christoph, CFO of NovoCure Ltd ($NVCR), made three open market purchases totaling nearly $232,000 in the last year, with the latest on July 29, 2025. These buys rank 1,422nd among nearly 5,000 insiders, below the average of $1.5 million across 3.3 transactions. He sold shares once for about $85,300, most recently on March 4, 2026, ranking 9,792nd among nearly 12,000 insiders versus an average of $8.6 million over 6.4 trades.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | S | Ordinary Shares | 6412 | $13.31 | 182,842.0000 | 111,981,981 | 3.39% | 0.01% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | A | Ordinary Shares | 55137 | $0.00 | 189,254.0000 | 111,981,981 | 41.11% | 0.05% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | A | Stock Option (Right to Buy) | 80674 | $0.00 | 80,674.0000 | 111,981,981 | 9999.99% | 0.07% |
| Nov. 4, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | F | Ordinary Shares | 7033 | $12.23 | 134,117.0000 | 111,981,981 | 4.98% | 0.01% |
| July 29, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 10000 | $11.63 | 131,150.0000 | 109,915,429 | 8.25% | 0.01% |
| July 29, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 5000 | $11.60 | 136,150.0000 | 109,915,429 | 3.81% | 0.00% |
| July 29, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | P | Ordinary Shares | 5000 | $11.50 | 141,150.0000 | 109,915,429 | 3.67% | 0.00% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Brackmann Christoph | Chief Financial Officer | A | Ordinary Shares | 54975 | $18.19 | 121,150.0000 | 109,915,429 | 83.08% | 0.05% |